Medical Research News

RSS

New treatment strategy for brain cancer

Virginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing radiation with a secreted protein that selectively inhibits tumor cell growth and survival can target cancer cells and leave healthy cells alone, perhaps presenting a new approach for treating the deadliest type of brain tumor.

9 Aug 2004

Effects of oxidative stress on atherosclerosis

Heart disease and stroke are the first and third leading causes of death among men and women in the United States and account for 40 percent of all mortalities, according to the Centers for Disease Control and Prevention.

9 Aug 2004

Possible role for BK virus in development of prostate cancer

Now, new research by scientists at the University of Michigan Medical School suggests the intriguing possibility that this common virus also may play a role in prostate cancer – the second-leading cause of deaths from cancer in American men.

9 Aug 2004

New screening tool prevents wrong patients from receiving Parkinson's surgery

The allure of a new brain surgery technique to relieve the stiffness and shaking caused by Parkinson’s disease may lead to unnecessary operations, University of Florida researchers say, but a new screening tool they developed could prevent potentially dangerous procedures.

9 Aug 2004

Research sheds new light on stepfamilies

Stepparents and non-resident parents play just as important role in the behaviour and well-being of their children as the parent they live with, New Zealand's Victoria University researchers have found.

9 Aug 2004

Significant advance in the understanding of the hepatitis C virus (HCV)

Researchers have made a significant advance in the understanding of the hepatitis C virus (HCV) by identifying new genetic factors associated with clearing the virus spontaneously without the necessity for additional treatment.

9 Aug 2004

Step closer to unravelling the mystery of medically unexplained pain such as chronic low back pain

Researchers are one step closer to unravelling the mystery of medically unexplained pain such as chronic low back pain, which continues to baffle doctors.

9 Aug 2004

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system that cause Australians incalculable distress as well as costing billions of dollars each year in treatment and care.

9 Aug 2004

Carb-conscious dieters may be lowering their risk of breast cancer

Carb-conscious dieters may be lowering their risk of breast cancer while they’re shedding pounds, based on the findings of research published in this month’s edition of the journal Cancer Epidemiology, Biomarkers & Prevention.

9 Aug 2004

Scientists lead fight against blood cancers

The Leukaemia Research Fund has awarded £140,000 to three teams working within the Nuffield Department of Clinical Laboratory Sciences to find and improve treatments for leukaemia and related blood cancers.

7 Aug 2004

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.

6 Aug 2004

World's young and leading scholars will gather in Sydney next week to showcase their research

Doctoral students from 36 of the world's leading universities will meet at the University of Sydney for a conference designed to foster cooperation in education and research.

6 Aug 2004

Short bouts of exercise reduce the risk of heart disease

Accumulated, short bouts of exercise are more effective than continuous exercise for lowering fat and triglyceride levels in the bloodstream after eating.

6 Aug 2004

Personalised medicine designed to enhance people's chances of quitting smoking

The latest spin-out from the University of Oxford, G-Nostics, focuses on personalised medicine designed to enhance people's chances of quitting smoking.

6 Aug 2004

Australian university signs multi-million dollar anti-cancer research deal

Australia's University of Newcastle Research Associates (TUNRA) Ltd has signed a licensing agreement worth approximately $10 million with the biotechnology company Psiron Ltd to develop anti-cancer treatments.

5 Aug 2004

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research with an aggressive set of technology initiatives. The goal is to take advantage of an explosion in new medical data to drive tighter linkage between research and the practice of medicine to achieve breakthroughs.

5 Aug 2004

First evidence of the molecular link between inflammation and cancer

The investigators found that a gene called I-kappa-B kinase (IKK beta), a pro-inflammatory gene, acts differently in two cell types to cause cancer. When IKK beta was deleted, the cancer incidence and tumor growth in mice was decreased by nearly 80 percent.

5 Aug 2004

New gene-silencing technique

A new gene-silencing technique that takes place in the nucleus of human cells, has been demonstrated by researchers at the University of California, San Diego (UCSD) School of Medicine and the VA San Diego Healthcare System.

5 Aug 2004

Potential of genomics in disease research yet to be realized

Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

5 Aug 2004

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.

5 Aug 2004